Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality

View ORCID ProfileJulio Silva, View ORCID ProfileCarolina Lucas, Maria Sundaram, Benjamin Israelow, Patrick Wong, Jon Klein, View ORCID ProfileMaria Tokuyama, View ORCID ProfilePeiwen Lu, Arvind Venkataraman, Feimei Liu, View ORCID ProfileTianyang Mao, View ORCID ProfileJi Eun Oh, View ORCID ProfileAnnsea Park, View ORCID ProfileArnau Casanovas-Massana, View ORCID ProfileChantal B. F. Vogels, M. Catherine Muenker, Joseph Zell, John B. Fournier, Melissa Campbell, Michael Chiorazzi, Edwin Ruiz Fuentes, Yale IMPACT Team, Nathan D. Grubaugh, Shelli Farhadian, Charles Dela Cruz, Albert I. Ko, View ORCID ProfileWade L. Schulz, View ORCID ProfileAaron Ring, Shuangge Ma, Saad Omer, View ORCID ProfileAnne L Wyllie, View ORCID ProfileAkiko Iwasaki
doi: https://doi.org/10.1101/2021.01.04.21249236
Julio Silva
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julio Silva
Carolina Lucas
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carolina Lucas
Maria Sundaram
2ICES, Toronto, ON, Canada
3University of Toronto Dalla Lana School of Public Health, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Israelow
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
4Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Wong
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Klein
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Tokuyama
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Tokuyama
Peiwen Lu
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peiwen Lu
Arvind Venkataraman
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feimei Liu
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tianyang Mao
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tianyang Mao
Ji Eun Oh
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ji Eun Oh
Annsea Park
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annsea Park
Arnau Casanovas-Massana
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arnau Casanovas-Massana
Chantal B. F. Vogels
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chantal B. F. Vogels
M. Catherine Muenker
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Zell
6Department of Medicine, Section of Pulmonary and Critical Care Medicine; Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John B. Fournier
4Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Campbell
4Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Chiorazzi
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin Ruiz Fuentes
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan D. Grubaugh
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelli Farhadian
4Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Dela Cruz
6Department of Medicine, Section of Pulmonary and Critical Care Medicine; Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert I. Ko
4Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wade L. Schulz
7Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA
8Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wade L. Schulz
Aaron Ring
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aaron Ring
Shuangge Ma
9Department of Biostatistics, Yale University, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saad Omer
4Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
10Yale Institute for Global Health, Yale University, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne L Wyllie
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne L Wyllie
Akiko Iwasaki
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
11Howard Hughes Medical Institute, Chevy Chase, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Akiko Iwasaki
  • For correspondence: akiko.iwasaki@yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

While several clinical and immunological parameters correlate with disease severity and mortality in SARS-CoV-2 infection, work remains in identifying unifying correlates of coronavirus disease 2019 (COVID-19) that can be used to guide clinical practice. Here, we examine saliva and nasopharyngeal (NP) viral load over time and correlate them with patient demographics, and cellular and immune profiling. We found that saliva viral load was significantly higher in those with COVID-19 risk factors; that it correlated with increasing levels of disease severity and showed a superior ability over nasopharyngeal viral load as a predictor of mortality over time (AUC=0.90). A comprehensive analysis of immune factors and cell subsets revealed strong predictors of high and low saliva viral load, which were associated with increased disease severity or better overall outcomes, respectively. Saliva viral load was positively associated with many known COVID-19 inflammatory markers such as IL-6, IL-18, IL-10, and CXCL10, as well as type 1 immune response cytokines. Higher saliva viral loads strongly correlated with the progressive depletion of platelets, lymphocytes, and effector T cell subsets including circulating follicular CD4 T cells (cTfh). Anti-spike (S) and anti-receptor binding domain (RBD) IgG levels were negatively correlated with saliva viral load showing a strong temporal association that could help distinguish severity and mortality in COVID-19. Finally, patients with fatal COVID-19 exhibited higher viral loads, which correlated with the depletion of cTfh cells, and lower production of anti-RBD and anti-S IgG levels. Together these results demonstrated that viral load – as measured by saliva but not nasopharyngeal — is a dynamic unifying correlate of disease presentation, severity, and mortality over time.

Competing Interest Statement

Akiko Iwasaki served as a consultant for Spring Discovery and Adaptive Biotechnologies

Funding Statement

This work was supported by the NIH Medical Scientist Training Program Training Grant T32GM136651; the Womens Health Research at Yale Pilot Project Program; Fast Grant from Emergent Ventures at the Mercatus Center, Mathers Foundation, and the Ludwig Family Foundation; the Department of Internal Medicine at the Yale School of Medicine; Yale School of Public Health and the Beatrice Kleinberg Neuwirth Fund. IMPACT received support from the Yale COVID-19 Research Resource Fund. A.I. is an Investigator of the Howard Hughes Medical Institute. C.L. is a Pew Latin American Fellow. P.Y is supported by Gruber Foundation and the NSF. B.I. is supported by NIAID 2T32AI007517-16. C.B.F.V. is supported by NWO Rubicon 019.181EN.004.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by Yale Human Research Protection Program Institutional Review Boards (FWA00002571, protocol ID 2000027690). Informed consent was obtained from all enrolled patients and healthcare workers.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the background information on HCWs, clinical information for patients, and raw data used in this study are included in Extended Table 4. Additionally, all of the raw .fcs files for the flow cytometry analysis are available

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted January 06, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality
Julio Silva, Carolina Lucas, Maria Sundaram, Benjamin Israelow, Patrick Wong, Jon Klein, Maria Tokuyama, Peiwen Lu, Arvind Venkataraman, Feimei Liu, Tianyang Mao, Ji Eun Oh, Annsea Park, Arnau Casanovas-Massana, Chantal B. F. Vogels, M. Catherine Muenker, Joseph Zell, John B. Fournier, Melissa Campbell, Michael Chiorazzi, Edwin Ruiz Fuentes, Yale IMPACT Team, Nathan D. Grubaugh, Shelli Farhadian, Charles Dela Cruz, Albert I. Ko, Wade L. Schulz, Aaron Ring, Shuangge Ma, Saad Omer, Anne L Wyllie, Akiko Iwasaki
medRxiv 2021.01.04.21249236; doi: https://doi.org/10.1101/2021.01.04.21249236
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality
Julio Silva, Carolina Lucas, Maria Sundaram, Benjamin Israelow, Patrick Wong, Jon Klein, Maria Tokuyama, Peiwen Lu, Arvind Venkataraman, Feimei Liu, Tianyang Mao, Ji Eun Oh, Annsea Park, Arnau Casanovas-Massana, Chantal B. F. Vogels, M. Catherine Muenker, Joseph Zell, John B. Fournier, Melissa Campbell, Michael Chiorazzi, Edwin Ruiz Fuentes, Yale IMPACT Team, Nathan D. Grubaugh, Shelli Farhadian, Charles Dela Cruz, Albert I. Ko, Wade L. Schulz, Aaron Ring, Shuangge Ma, Saad Omer, Anne L Wyllie, Akiko Iwasaki
medRxiv 2021.01.04.21249236; doi: https://doi.org/10.1101/2021.01.04.21249236

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1962)
  • Dentistry and Oral Medicine (253)
  • Dermatology (187)
  • Emergency Medicine (335)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (703)
  • Epidemiology (11123)
  • Forensic Medicine (8)
  • Gastroenterology (629)
  • Genetic and Genomic Medicine (3196)
  • Geriatric Medicine (310)
  • Health Economics (567)
  • Health Informatics (2049)
  • Health Policy (864)
  • Health Systems and Quality Improvement (789)
  • Hematology (310)
  • HIV/AIDS (685)
  • Infectious Diseases (except HIV/AIDS) (12742)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (337)
  • Neurology (3004)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1561)
  • Ophthalmology (478)
  • Orthopedics (186)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (386)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2799)
  • Public and Global Health (5613)
  • Radiology and Imaging (1101)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (764)
  • Rheumatology (341)
  • Sexual and Reproductive Health (315)
  • Sports Medicine (289)
  • Surgery (348)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)